Everything that comes from ATI consortia etc
Anticipated Release Date: Q3FY25 PPTS-ENBD will provide a biocontainment isolation system to safely transport personnel infected or suspected of infection from a biological threat. Responding to this opportunity requires membership in the Countering Weapons of Read More
Due: October 15, 2024 Chemical Biological Center, Research and Technology Directorate, Sensor Technologies and BioMaterials Division, Spectroscopy Branch is seeking a solution for sensitive and selective detection of hazardous vapors. To develop a handheld, battery-operated, Read More
Due: November 1, 2024 This solicitation is issued by the MCDC Consortium Manager (CM), Advanced Technology International (ATI), represents a Request for Project Proposals (RPP) for the 2024 “MCDC Commercialization Grant” mechanism. Responding to this Read More
Due: November 6, 2024 Seeking chemicals suppliers to create a more resilient industrial base, increase domestic capacity, increase competition, and thereby drive down chemical products cost. This opportunity may require no-cost membership in DIBC. This Consortium Read More
Due: November 1, 2024 This solicitation is issued by the CWMD Consortium Manager (CM), Advanced Technology International (ATI), represents a Request for Project Proposals (RPP) for the 2024 “CWMD Commercialization Grant” mechanism. Responding to this Read More
Anticipated Release Date: Q3FY26 ASPIRE will provide respiratory and ocular protection against Chemical, Biological, Radiological and Nuclear threats that allows near normal operations by minimizing or eliminating physical and psychological burden and increasing Warfighter lethality. Read More
Anticipated Release Date: Q3FY25 This topic aims to provide novel, low-burden masks for the general purpose warfighter utilizing innovative materials and custom manufacturing processes. These materials and processes will make these masks bespoke to users’ Read More
Anticipated Release Date: Q1FY25 New start OTA award for ADTX Responding to this opportunity requires membership in the Countering Weapons of Mass Destruction Consortium. This Consortium releases numerous solicitations throughout the year, so even if this Read More
Anticipated Release Date: Q4FY24 Development of alternate large animal models for biothreats (viral and toxin) and chemical threats. Due to the limited supply of non-human primates, the CBDP is investing in alternative models for threat Read More
Anticipated Release Date: Q4FY24 The prioritizations on broad-spectrum direct-acting antivirals (nucleoside/nucleotide-like compounds and combination therapies) and host-directed broad-spectrum antivirals and antibacterials such as molecules that target host signaling pathways, are involved in entry and replication, Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.